In a recent statement, a senior US health official emphasized that national vaccine guidelines are not static and remain subject to updates based on evolving scientific evidence. The official noted that agencies like the CDC and NIH continuously review new data on vaccine efficacy, safety, and emerging virus variants. This ongoing assessment process means recommendations for booster shots, dosing intervals, and eligibility for different age groups could be revised. The statement underscores the adaptive nature of public health policy in response to a changing pandemic landscape. Read the full article for more details: https://www.technologyreview.com/2026/02/13/1132889/us-deputy-health-secretary-vaccine-guidelines-longevity-arpa-h-cdc-nih/